Scilex Holding SCLX
NASDAQ SCLX
$5.80 -0.01 (-0.09%)
As of: Aug 21, 2026 · 12:35 PM EDT

Scilex Holding (SCLX) FCF Margin (2022 - 2026)

Scilex Holding (SCLX) posted quarterly FCF Margin of 19.91% for Q1 2026, down 14005.0% year-over-year from N/an in Q1 2025, and up 94.49% quarter-over-quarter from 361.3% in Q4 2025.

Scilex Holding (SCLX) FCF Margin (2022 - 2026) Analysis & Trends

Scilex Holding's FCF Margin history runs 5 years deep, the most recent figure standing at 19.91% for Q1 2026.

  • In Q1 2026, FCF Margin fell 14005.0% year-over-year to 19.91%; the TTM figure through Mar 2026 stood at 11.52% (down 4306.0% YoY), while the FY2025 annual figure was 12.58%, down 2160.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 19.91%, up from 361.3% in the prior quarter.
  • The five-year high for FCF Margin was 120.14% in Q1 2025, with the low at 361.3% in Q4 2025.
  • The 5-year median for FCF Margin is 14.12% (2024), against an average of 23.83%.
  • The sharpest annual moves came in 2024 and 2025: FCF Margin surged 14977 bps in 2024, then sank 37850 bps in 2025.
  • Scilex Holding's FCF Margin stood at 6.38% in 2022, then slumped by 522 bps to 39.66% in 2023, then surged by 143 bps to 17.2% in 2024, then tumbled by 2201 bps to 361.3% in 2025, then surged by 94 bps to 19.91% in 2026.
  • Business Quant data shows SCLX's FCF Margin at 19.91% in Q1 2026, 361.3% in Q4 2025, and 78.06% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 653.18 Bn 632.42 Bn 17.26 Bn 28.82%
2 AbbVie 470.13 Bn 463.56 Bn 12.70 Bn 18.33%
3 Merck 376.16 Bn 369.02 Bn 12.21 Bn 26.96%
4 Novartis Ag 302.69 Bn 295.00 Bn 11.24 Bn 38.60%
5 Astrazeneca 257.73 Bn 252.83 Bn 12.86 Bn -12.07%
6 Amgen 236.53 Bn 222.54 Bn 7.24 Bn 34.70%
7 Gilead Sciences 183.21 Bn 180.03 Bn 6.22 Bn 44.00%
8 Pfizer 160.17 Bn 148.47 Bn 10.94 Bn 2.01%
9 Gsk 105.91 Bn 101.75 Bn 8.24 Bn 3.90%
10 Scilex Holding 39.90 Mn -72.88 Mn 3.97 Mn -93.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.91%
Dec 31, 2025 -361.30%
Sep 30, 2025 78.06%
Jun 30, 2025 71.24%
Mar 31, 2025 120.14%
Dec 31, 2024 17.20%
Sep 30, 2024 35.42%
Jun 30, 2024 14.12%
Mar 31, 2024 86.01%
Dec 31, 2023 -39.66%
Sep 30, 2023 66.34%
Jun 30, 2023 -115.07%
Mar 31, 2023 -63.76%
Dec 31, 2022 -6.38%
Sep 30, 2022 25.65%
Jun 30, 2022 -155.63%
Mar 31, 2022 -157.53%